Total Payments
$3,879
2024 Payments
$1,695
Companies
39
Transactions
184
Medicare Patients
1,167
Medicare Billing
$163,866
Payment Breakdown by Category
Food & Beverage$3,572 (92.1%)
Education$306.20 (7.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,572 | 180 | 92.1% |
| Education | $306.20 | 4 | 7.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $442.02 | 22 | $0 (2024) |
| Lilly USA, LLC | $351.54 | 9 | $0 (2024) |
| Astellas Pharma US Inc | $251.60 | 9 | $0 (2024) |
| ABBVIE INC. | $228.63 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $182.99 | 10 | $0 (2024) |
| PFIZER INC. | $182.12 | 10 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $155.82 | 8 | $0 (2024) |
| Genentech USA, Inc. | $153.09 | 6 | $0 (2024) |
| Janssen Biotech, Inc. | $145.96 | 7 | $0 (2023) |
| Eisai Inc. | $143.58 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,695 | 83 | Celgene Corporation ($244.19) |
| 2023 | $873.58 | 43 | Celgene Corporation ($114.89) |
| 2022 | $850.42 | 41 | Astellas Pharma US Inc ($131.20) |
| 2021 | $459.27 | 17 | Lilly USA, LLC ($256.84) |
All Payment Transactions
184 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $29.10 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Genentech USA, Inc. | Columvi (Biological), Lunsumio, Polivy | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: BioOncology | ||||||
| 12/10/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/05/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/04/2024 | Biocon Biologics Inc | Fulphila (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Oncology | ||||||
| 12/03/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $28.39 | General |
| Category: Oncology | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $27.59 | General |
| Category: Immunology | ||||||
| 11/22/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $26.14 | General |
| Category: Hematology | ||||||
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ALUNBRIG (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 11/01/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 10/21/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $25.97 | General |
| 10/17/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $1.41 | General |
| 10/10/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: Oncology | ||||||
| 10/02/2024 | ABBVIE INC. | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: ONCOLOGY | ||||||
| 09/27/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $21.44 | General |
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Oncology | ||||||
| 08/20/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $26.28 | General |
| Category: Oncology | ||||||
| 08/12/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $31.65 | General |
| Category: ONCOLOGY | ||||||
| 08/07/2024 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $35.92 | General |
| Category: Hematology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 376 | 934 | $222,476 | $54,627 |
| 2022 | 2 | 333 | 733 | $184,369 | $46,629 |
| 2021 | 3 | 247 | 548 | $99,025 | $37,550 |
| 2020 | 2 | 211 | 449 | $66,275 | $25,059 |
Total Patients
1,167
Total Services
2,664
Medicare Billing
$163,866
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 219 | 578 | $212,704 | $50,339 | 23.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 146 | 345 | $4,140 | $2,890 | 69.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $5,632 | $1,398 | 24.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 224 | 514 | $181,916 | $45,981 | 25.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 109 | 219 | $2,453 | $647.85 | 26.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 153 | 390 | $93,821 | $35,381 | 37.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 20 | 26 | $3,778 | $1,773 | 46.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 74 | 132 | $1,427 | $396.00 | 27.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 140 | 328 | $64,944 | $24,702 | 38.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 71 | 121 | $1,331 | $357.36 | 26.8% |
About Caryn Ecker, NP
Caryn Ecker, NP is a Acute Care healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/20/2010. The National Provider Identifier (NPI) number assigned to this provider is 1427351063.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Caryn Ecker, NP has received a total of $3,879 in payments from pharmaceutical and medical device companies, with $1,695 received in 2024. These payments were reported across 184 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($3,572).
As a Medicare-enrolled provider, Ecker has provided services to 1,167 Medicare beneficiaries, totaling 2,664 services with total Medicare billing of $163,866. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Acute Care
- Location New York, NY
- Active Since 12/20/2010
- Last Updated 12/20/2010
- Taxonomy Code 363LA2100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1427351063
Products in Payments
- RETEVMO (Drug) $241.18
- IMBRUVICA (Drug) $199.38
- Pomalyst (Drug) $198.92
- LIBTAYO (Biological) $153.10
- KRAZATI (Drug) $146.68
- ZEPZELCA (Drug) $135.15
- Lenvima (Drug) $124.70
- REBLOZYL (Biological) $122.90
- VERZENIO (Drug) $110.36
- KISQALI (Drug) $105.65
- Padcev (Drug) $104.27
- EPKINLY (Drug) $102.24
- Rezlidhia (Drug) $100.36
- OPDIVO (Biological) $88.44
- JAKAFI (Drug) $84.73
- INLYTA (Drug) $83.08
- TAGRISSO (Drug) $66.87
- DARZALEX (Biological) $62.89
- PADCEV (Biological) $58.92
- Venclexta (Biological) $58.74
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acute Care Doctors in New York
Mr. Daniel Verina, Np, NP
Acute Care — Payments: $387,089
Acute Care $387,089
Mrs. Katie Worthington, Agacnp-Bc, AGACNP-BC
Acute Care — Payments: $15,737
Acute Care $15,737
Julia Cereda, Agacnp-Bc, AGACNP-BC
Acute Care — Payments: $9,648
Acute Care $9,648
Julie Anne Roldan
Acute Care — Payments: $8,351
Acute Care $8,351
Ms. Kristen Donchez, Acnpc-Ag, ACNPC-AG
Acute Care — Payments: $7,847
Acute Care $7,847
Kathryn Ciccolini, Agacnp-Bc, AGACNP-BC
Acute Care — Payments: $6,069
Acute Care $6,069